Capso Vision
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Capso Vision sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Capso Vision: 6 sponsored US clinical trials, 1 recruiting.
Capso Vision sponsors 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is Colonic Polyps, with 2 trials.
Upper-quartile sponsor footprint
Capso Vision sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference
NCT07089615
Data Collection for CV-3E AI Software Development
NCT06916845
Pivotal Study of the CapsoCam Colon (CV-3) in Detecting Colonic Polyps, Using Colonoscopy as the Reference
NCT04607746
CapsoCam® Colon Capsule Endoscope (CCE) Compared to Colonoscopy (OC)
NCT04246632
Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System
NCT04573959
Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease
NCT01787825
Therapeutic Areas
What is open in the Capso Vision pipeline
1 recruiting of 6 indexed (17% open); 5 completed (83%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Colonic Polyps (2 trials), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Capso Vision: open-pipeline peers nationwide
Peers matched on 6 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Capso Vision sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this Capso Vision page
6 registered trials is a research-attention snapshot, not an endorsement of Capso Vision or any single study.
- 1 of Capso Vision's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Colonic Polyps is the condition Capso Vision studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Colonic Polyps trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Capso Vision pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.